Newcleo, a leader in advanced modular reactor technology, announced it will acquire Bonifait Pesage, a French maker of nuclear-grade scales. This acquisition strengthens Newcleo's vertical integration by bringing critical manufacturing capabilities in-house, securing preferred access to precision weighing equipment essential for nuclear fuel production, and reducing supply chain risks. The deal supports Newcleo's planned MOX fuel manufacturing facilities and is expected to close in Q4 2026. This move aligns with Newcleo's strategy to expand its nuclear fuel manufacturing and supply chain control ahead of its planned Nasdaq listing later in 2026.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
